risperidone has been researched along with Diathesis in 6 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Six of 13 outpatients with schizophrenia who participated in a ten-week open trial of risperidone had an initial good response to the medication followed by development of intolerable affect, including feelings of agitation and depression and periods of crying and insomnia." | 9.08 | A syndrome of increased affect in response to risperidone among patients with schizophrenia. ( Ashleigh, EA; Larsen, PD, 1998) |
| "Six of 13 outpatients with schizophrenia who participated in a ten-week open trial of risperidone had an initial good response to the medication followed by development of intolerable affect, including feelings of agitation and depression and periods of crying and insomnia." | 5.08 | A syndrome of increased affect in response to risperidone among patients with schizophrenia. ( Ashleigh, EA; Larsen, PD, 1998) |
| "Less convincing suggestions relate jet lag to psychosis." | 1.31 | [Jet lag causing or exacerbating psychiatric disorders]. ( Durst, R; Katz, G; Knobler, H; Knobler, HY; Zislin, J, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Çirakli, S | 1 |
| Schwarz, E | 1 |
| Steiner, J | 1 |
| Guest, PC | 1 |
| Bogerts, B | 1 |
| Bahn, S | 1 |
| Breekveldt-Postma, NS | 1 |
| Schillevoort, I | 1 |
| Nolen, WA | 1 |
| Veraart, CP | 1 |
| Herings, RM | 1 |
| Ashleigh, EA | 1 |
| Larsen, PD | 1 |
| Lewis, R | 1 |
| Katz, G | 1 |
| Durst, R | 1 |
| Zislin, J | 1 |
| Knobler, H | 1 |
| Knobler, HY | 1 |
1 review available for risperidone and Diathesis
| Article | Year |
|---|---|
Typical and atypical antipsychotics in adolescent schizophrenia: efficacy, tolerability, and differential sensitivity to extrapyramidal symptoms.
Topics: Adolescent; Adolescent Psychiatry; Age Factors; Antipsychotic Agents; Benzodiazepines; Cholinergic F | 1998 |
1 trial available for risperidone and Diathesis
| Article | Year |
|---|---|
A syndrome of increased affect in response to risperidone among patients with schizophrenia.
Topics: Adult; Antipsychotic Agents; Anxiety; Disease Susceptibility; Follow-Up Studies; Humans; Male; Middl | 1998 |
4 other studies available for risperidone and Diathesis
| Article | Year |
|---|---|
Childhood dystonic reactions in the middle Black Sea region.
Topics: Age of Onset; Antipsychotic Agents; Aripiprazole; Biperiden; Child; Disease Susceptibility; Dopamine | 2021 |
Investigation of molecular serum profiles associated with predisposition to antipsychotic-induced weight gain.
Topics: Adult; Antipsychotic Agents; Body Mass Index; Clozapine; Disease Susceptibility; ErbB Receptors; Fem | 2015 |
Selective prescribing of atypical antipsychotics.
Topics: Adult; Aged; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Cholinergic Antagonists; | 2005 |
[Jet lag causing or exacerbating psychiatric disorders].
Topics: Antipsychotic Agents; Disease Susceptibility; Humans; Jet Lag Syndrome; Male; Middle Aged; Psychotic | 2000 |